FDA Inspection
Aurisco Pharmaceutical Co., LtdAurisco Pharmaceutical Co., Ltd – FDA Inspection, Jan 25, 2019
Record Details
This FDA Inspection record concerns Aurisco Pharmaceutical Co., Ltd, with an inspection on January 25, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 7871a8ec-f0ba-4f63-8279-65bfe33269a4
Inspection Facts
- Inspection number
- 1079222
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Aurisco Pharmaceutical Co., Ltd
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 21, 2025 | Not classified | Office of Inspections and Investigations | |
| November 30, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 15, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aurisco Pharmaceutical Co., Ltd
- FDA Inspection 1269298 - 2025-03-21
- FDA Inspection 1077584 - 2018-11-30
- FDA Inspection 856482 - 2013-11-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.